Introduction
of uptake, endosomal loading into major histocompatibility complex (MHC) class II, cross-presentation into MHC class I and cell membrane presentation, and also by non-classical extracellular binding in MHC class II grooves, skipping the classical intracellular route
. For myelin proteins, it has been shown that the extracellular proteolysis by gelatinase B releases a burden of immunodominant epitopes that may act as encephalitogens in MS [4] . For rheumatoid arthritis, collagen type II degradation was suggested as a source for disease-promoting peptides [5] .
AU is a clinically heterogenous group of diseases [6] . [7, 8] . [9] . Ankylosing spondylitis is an autoimmune disease, associated with the expression of class I MHC antigen HLA-B27 [10] . Chronic postoperative bacterial endophthalmitis is most often observed after cataract surgery [11] 
Behcet disease is a systemic vasculitis with unclear aetiology and pathogenesis. High prevalence of HLA-B51, T helper type 1 cellmediated immune response, neutrophil hyperfunction and increased expression of heat shock protein 60 in the patients are considered important in the pathogenesis

Gel zymography and Western blot analysis
The presence of gelatinase B/MMP-9 in aqueous fluids was determined by zymography according to standardized laboratory protocols [15] 
Purification of human IRBP
First, we established the purification procedure with bovine material. Bovine eyes were collected, the retinas removed and extracted as described [17] . Human IRBP purification was done on post-mortem donor retinas. Retinas were pooled in 0.14 M NaCl, 10 mM Tris solution (pH 7.0) (1ml/retina), stirred at low speed (20 rpm) 
Statistical analysis
Because of the large variances in the raw data for gelatinase B, IgG and IRBP, the correlations between these variables and the disease activity were investigated using Spearman's rank correlation coefficient. The differences were considered significant if the P value was <0.05.
Results
The presence of IRBP in aqueous humour samples is related to uveitic activity, gelatinase B content and blood-ocular barrier integrity Fig. 2A . Almost complete degradation of full-length IRBP was obtained within 80 min. After 160 min., only a 55 kD fragment was detected in the reaction mixture. At other time-points, also other molecular weight degradation products were detected.
Degradation of IRBP in vitro Gelatinase A (MMP-2), elastase and cathepsin G activity were previously found in subretinal fluid of retinal detachment (RD) patients and were hypothesized to be important for the loosening of RPE cells from their monolayer [18]. Since IRBP is a secreted protein, we tested each of these enzymes as candidate proteases. Pure enzyme preparations were added to crude vitreous fluid containing full-length IRBP. Neutrophil elastase cleaved IRBP more efficiently compared to MMP-2 and cathepsin G (data not shown). Therefore, further characterization of the cleavage of IRBP by neutrophil elastase was performed. The degradation of human IRBP in function of time was investigated by sampling a 10 l reaction mixture containing 400 nM IRBP and 8 nM elastase (enzyme : substrate ratio = 1:50; incubation at 37°C). A Western blot analysis of 1 l samples, which were taken at various time-points, is shown in
As a representation of leukocyte protein release and a natural source of extracellular proteases, we used conditioned medium of human neutrophils that had been stimulated to degranulate with the bacterial formylpeptide fMLP. IRBP (400 nM) was incubated with 0.4 l neutrophilic degranulate which is a physiologically relevant amount since it yields a final MMP-9 concentration that is comparable to that of aqueous humour samples from patients with uveitis (~1 nM). By the presence of other proteases in the neutrophil degranulate, IRBP was completely proteolysed, similarly as observed in vivo.
Effect of treatment
The biological links between the used parameters were tested further by analysis of aqueous humour samples from two patients with systemic autoimmune disease with eye infliction, before and after treatment. One patient had uveitis (clinically scored 3) associated with ankylosing spondylitis before treatment (Fig. 1A, lower (Fig. 1A, lower part, (Fig. 1C) . We could evaluate two additional serial samples after initiation of topical and systemic corticosteroids combined with cyclosporine A therapy in this patient. [19] . This may shed new light on the hidden nature of IRBP and its role of dominant autoantigen [6, 20] [21, 22] and experimental autoimmune uveoretinitis [23, 24] . Moreover, neutrophil accumulation correlates with MMP-9 activity in endotoxin-induced uveitis [12] . Both [25] . In addition to the relevance of proteolysis in autoantigen processing in the heterogenous groups of AU conditions [6] [7] [8] [9] [10] 26] , the concept is also applicable in other forms of eye inflammation, including chronic endophthalmitis, infections and idiopathic forms of eye inflammation [27] .
part, first lane from left). One week after topical corticosteroid treatment, MMP-9 disappeared
second lane from left). The other patient with Behcet disease had hypopyon before treatment, high IgG and MMP-9 levels and no detectable intact IRBP. The presence of the covalent complex between MMP-9 and neutrophil gelatinase B-associated lipocalin is a further indication of high neutrophil counts in the aqueous humour of this patient with Behcet disease
During this therapy, the MMP-9 and IgG levels gradually and progressively disappeared and intact IRBP reappeared. The reappearance of intact IRBP in the aqueous fluid, concomitant with clinical improvement, further substantiates that IRBP breakdown is
Finally, our study also demonstrates that reversal of IRBP degradation, and hence avoidance of a positive autoimmune feedback loop, is obtained after immunosuppressive therapy. We show that corticosteroids, known to reduce cellular MMP-9 and MMP-2 production in vitro [28] 
